<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03251638</url>
  </required_header>
  <id_info>
    <org_study_id>Assuit</org_study_id>
    <nct_id>NCT03251638</nct_id>
  </id_info>
  <brief_title>Neonatal Hearing Screening in Assiut Hospital</brief_title>
  <official_title>Neonatal Hearing Screening at Neonatal Intensive Care Unit of Assiut University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hearing loss is one of the most common congenital anomalies. Early Intervention at or before&#xD;
      6 months of age allows a child with impaired hearing to develop normal speech and&#xD;
      language.Auditory brainstem response , otoacoustic emissions testing have all been used in&#xD;
      newborn hearing-screening programs&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hearing loss is one of the most common congenital anomalies . It has been shown to be greater&#xD;
      than that of most other diseases and syndromes (eg, phenylketonuria, sickle cell disease)&#xD;
      screened at birth . Data from the newborn hearing-screening programs in Rhode Island,&#xD;
      Colorado, and Texas showed that 2-4 of every 1000 neonates have hearing loss.&#xD;
&#xD;
      Early Intervention at or before 6 months of age allows a child with impaired hearing to&#xD;
      develop normal speech and language, alongside his or her hearing peers and can prevent severe&#xD;
      psychosocial, educational, and language impairment.( One of the most high risk population are&#xD;
      neonates who spend time in the newborn intensive care unit, exposed to high frequency&#xD;
      ventilation, hyperbilirubinemia, low birth-weight, and exposed to ototoxic medications.&#xD;
&#xD;
      Auditory brainstem response, otoacoustic emissions , and automated Auditory brainstem&#xD;
      response testing have all been used in newborn hearing-screening programs. otoacoustic&#xD;
      emissions are fast objective, efficient, and frequency-specific measurements of peripheral&#xD;
      auditory sensitivity are used to assess response of the outer hair cells to acoustic stimuli.&#xD;
      To measure otoacoustic emissions, a probe assembly is placed in the ear canal, tonal or click&#xD;
      stimuli are delivered, and the otoacoustic emissions generated by the cochlea is measured&#xD;
      with a microphone .&#xD;
&#xD;
      Currently, 2 types of evoked otoacoustic emissions measurements are used for newborn hearing&#xD;
      screening: transient evoked otoacoustic emissions and distortion product otoacoustic&#xD;
      emissions . Provided that the patient's middle ear function is normal, these measurements can&#xD;
      be used to assess cochlear function for the 500-6000 Hz frequency range. The presence of&#xD;
      evoked otoacoustic emissions responses indicates hearing sensitivity in the normal to&#xD;
      near-normal range .&#xD;
&#xD;
      The Auditory brainstem response test records brainstem electrical activity in response to&#xD;
      sounds presented to the infant via earphones. In contrast to the otoacoustic emissions test,&#xD;
      the The Auditory brainstem response evaluates the auditory pathway from the external ear to&#xD;
      the level of the brainstem, enabling diagnosis of auditory neuropathy, which is a less common&#xD;
      cause of hearing impairment .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal hearing screening</measure>
    <time_frame>6months</time_frame>
    <description>number of neonates who failed to pass emissions</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Neonatal Hearing Impairment</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates who admitted at neonatal intensive care unit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A) Neonates of both sexes. (B) Neonates with the following risk factors according to&#xD;
             the Joint Committee on Infant Hearing 2000 Position Statement:&#xD;
&#xD;
               -  In utero infection such as cytomegalovirus, rubella, toxoplasmosis, or herpes.&#xD;
&#xD;
               -  Neonatal indicators, specifically hyperbilirubinemia at a serum level requiring&#xD;
                  exchange transfusion, persistent pulmonary hypertension of the newborn associated&#xD;
                  with mechanical ventilation, and conditions requiring the use of extracorporeal&#xD;
                  membrane oxygenation&#xD;
&#xD;
               -  Low birth weight (1500-1800)grams&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Absence of high risk factors in the neonates.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nafesa Hs Rafat, Prof</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_contact>
    <last_name>Eman AF Sayed, As.Prof</last_name>
    <phone>0201156383841</phone>
    <email>emanelgendy40@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samah M Ahmed, lecturer</last_name>
    <phone>0201003272437</phone>
    <email>Samahoraky@yahoo.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Connolly JL, Carron JD, Roark SD. Universal newborn hearing screening: are we achieving the Joint Committee on Infant Hearing (JCIH) objectives? Laryngoscope. 2005 Feb;115(2):232-6.</citation>
    <PMID>15689741</PMID>
  </results_reference>
  <results_reference>
    <citation>Downs MP. Universal newborn hearing screening--the Colorado story. Int J Pediatr Otorhinolaryngol. 1995 Jul;32(3):257-9.</citation>
    <PMID>7665273</PMID>
  </results_reference>
  <results_reference>
    <citation>Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics. 1999 Feb;103(2):527-30.</citation>
    <PMID>9925859</PMID>
  </results_reference>
  <results_reference>
    <citation>Finitzo T, Albright K, O'Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics. 1998 Dec;102(6):1452-60.</citation>
    <PMID>9832584</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams TR, Alam S, Gaffney M; Centers for Disease Control and Prevention (CDC). Progress in identifying infants with hearing loss-United States, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015 Apr 10;64(13):351-6.</citation>
    <PMID>25856256</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>August 12, 2017</study_first_submitted>
  <study_first_submitted_qc>August 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2017</study_first_posted>
  <last_update_submitted>August 19, 2017</last_update_submitted>
  <last_update_submitted_qc>August 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Nesma Gamal</investigator_full_name>
    <investigator_title>Neonatal Hearing Screeing at Neonatal Intensive Care Unit of Assiut University Hospital</investigator_title>
  </responsible_party>
  <keyword>NHS( newborn hearing screening )</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

